Literature DB >> 11095786

New Thoughts on Pathogenesis and Diagnosis of Encephalitis.

.   

Abstract

Knowledge regarding the pathogenesis of viral encephalitis, defined as inflammation and destruction of the central nervous system (CNS) from viral infection and the resulting immune response, has improved with advances in molecular biology techniques and recent advances in immunology and neuroscience research. An increasingly complex understanding has developed with regard to viral CNS infection. In addition to advances in viral genetics exploring increased viral spread and neurovirulence, improved understanding from research on neurochemistry, neurodevelopment, and cytokine expression in the CNS has led to new hypotheses regarding the mechanism of CNS damage during viral CNS infection. This review explores three advances in the understanding of viral encephalitis in the past few years: 1) the relationship between viral load and extent of viral CNS disease, 2) chemokines and their role in the CNS inflammatory response as well as in the pathogenesis of encephalitis, and 3) secondary damage from the release of neurotoxins during encephalitis. By examining this research, the reviewers intend to introduce novel therapeutic modalities that are developing for the management of patients with viral encephalitis beyond the timely use of antiviral therapy.

Entities:  

Year:  1999        PMID: 11095786     DOI: 10.1007/s11908-996-0027-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  62 in total

Review 1.  Chemokines and ocular pathology caused by corneal infection with herpes simplex virus.

Authors:  U Kumaraguru; I Davis; B T Rouse
Journal:  J Neurovirol       Date:  1999-02       Impact factor: 2.643

2.  Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.

Authors:  V G Sasseville; M M Smith; C R Mackay; D R Pauley; K G Mansfield; D J Ringler; A A Lackner
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction.

Authors:  L Monno; M Di Stefano; G B Zimatore; C F Andreula; A Appice; L M Perulli; J R Fiore; G Pastore; G Angarano
Journal:  AIDS       Date:  1998-04-16       Impact factor: 4.177

4.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.

Authors:  Q Ma; D Jones; P R Borghesani; R A Segal; T Nagasawa; T Kishimoto; R T Bronson; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

5.  Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3.

Authors:  E Garcion; L Sindji; C Montero-Menei; C Andre; P Brachet; F Darcy
Journal:  Glia       Date:  1998-03       Impact factor: 7.452

6.  Round cell variant of measles virus: neurovirulence and pathogenesis of acute encephalitis in newborn hamsters.

Authors:  D R Carrigan
Journal:  Virology       Date:  1986-01-30       Impact factor: 3.616

7.  Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo.

Authors:  J Dockter; C F Evans; A Tishon; M B Oldstone
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Activated human microglia produce the excitotoxin quinolinic acid.

Authors:  M G Espey; O N Chernyshev; J F Reinhard; M A Namboodiri; C A Colton
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

9.  Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection.

Authors:  M A Billstrom; G L Johnson; N J Avdi; G S Worthen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain.

Authors:  C K Petito; K S Cash
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.